{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-23-000641","form_type":"8-K","ticker":"LCTC","cik":"0001493137","company_name":"Lifeloc Technologies, Inc","filed_at":"2023-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.034048+00:00","generated_at":"2026-06-15T08:52:19.425998+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Lifeloc Q1 net loss narrows to $54K; revenue flat at $2.165M","bullets":["Net revenue $2.165M flat YoY; net loss $(54)K ($0.02/sh) vs $(145)K loss ($0.06/sh) in Q1 2022.","Gross margin improved to 43.2% from 39.0% YoY, driven by price increases and lower depreciation.","R&D spending increased for SpinDx THC saliva testing platform; commercialization expected in 2024.","Supply chain constraints held back sales but component lead times shortening; backlog expected to be fulfilled in Q2.","Company implemented additional price increases for 2023 to offset component inflation."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-23-000641","json":"https://secwatch.observer/filing/0001079973-23-000641.json","markdown":"https://secwatch.observer/filing/0001079973-23-000641.md","text":"https://secwatch.observer/filing/0001079973-23-000641.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1493137/000107997323000641/0001079973-23-000641-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1493137/000107997323000641/lclc_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T08:52:19.425998+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5e7def15189ae543da44af5b3d84e163e27251af","claim":"Lifeloc Technologies, Inc reported first quarter ended March 31, 2023 results: revenue $2.165 million, net income $(54) thousand, EPS $(0.02) per diluted share.","evidence_excerpt":"Lifeloc posted quarterly net revenue of $2.165 million resulting in a quarterly net loss of $(54) thousand, or $(0.02) per diluted share.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1493137/000107997323000641/0001079973-23-000641-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2023"},{"label":"Revenue","value":"$2.165 million"},{"label":"Net income","value":"$(54) thousand"},{"label":"EPS","value":"$(0.02) per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}